Clinical trial
A Phase I, Single-center, Randomized, Double-blind, Single-dose, Dose-ascending, Placebo-controlled Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.
NCT06267183 is registered in ClinicalTrials.gov with Shanghai Synvida Biotechnology Co.,Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I, Single-center, Randomized, Double-blind, Single-dose, Dose-ascending, Placebo-controlled Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.
- Lead sponsor
- Shanghai Synvida Biotechnology Co.,Ltd.
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- January 12, 2024
- Completion date
- December 30, 2026
- Enrollment
- 53 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.